Vandana Singh

Contributing Author

Recent Articles by Vandana Singh

Feb-06	Roivant Stock Soars On Experimental Skin Drug Delivering 100% Response - Why It Matters ROIV +22.14% Benzinga
Feb-06	Pulse Biosciences Heart Device Data Fuels Stock Surge PLSE +51.57% Benzinga
Feb-06	Early uniQure Fabry Trial Shows Lasting Enzyme Boost, Safety Watch QURE Benzinga
Feb-06	CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder AMGN LLY CVS ABBV Benzinga
Feb-06	What's Going On With Novo Nordisk Stock On Friday? NVO +9.92% HIMS Benzinga
Feb-06	Centene Takes A Hit As Medicaid Membership Shrinks CNC Benzinga
Feb-06	Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump BIIB +8.53% Benzinga
Feb-05	Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst LLY -7.79% Benzinga
Feb-05	Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action NVO +9.92% NVO -8.16% HIMS Benzinga
Feb-05	FTC Settlement With Cigna's Pharmacy Benefit Manager Promises Cheaper Insulin, Boosts Dividend On Strong Quarterly Earnings CI UNH CVS Benzinga
Feb-05	Cardinal Health Smashes 52-Week High After Strong Quarter CAH +9.83% Benzinga
Feb-05	Bristol Myers Flags Data-Rich 2026 After Solid Quarter BMY Benzinga
Feb-05	EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings NXL +9.15% Benzinga
Feb-05	EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery VSEE Benzinga
Feb-04	In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk LLY +10.33% NVO -6.18% Benzinga
Feb-04	GE HealthCare Beats Earnings But Margin Pressure, Tariff Costs Could Weigh On Profitability GEHC Benzinga
Feb-04	AbbVie's Inflammation Drug Humira Slows, But Skyrizi, Rinvoq Drive Revenue Growth ABBV Benzinga
Feb-04	Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead NVS Benzinga
Feb-04	Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss COR -8.79% COR +6.72% Benzinga
Feb-04	Boston Scientific Stock Hits 52-Week Low On Soft 2026 Outlook BSX -17.59% Benzinga
Feb-04	Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs LLY +10.33% NVO -6.18% Benzinga
Feb-04	GSK Stock Smashes 52-Week High On Strong Quarter, Dividend Hike GSK +7.29% Benzinga
Feb-04	Ozempic Maker Novo Nordisk Flags Declining Sales In 2026 NVO -6.18% Benzinga
Feb-03	Novo Nordisk Stock Falls As 2026 Outlook Signals Pricing Pressure, Slowing Sales NVO -14.64% Benzinga
Feb-03	Ultragenyx Says Gene Therapy Shows Lasting Benefits, Slows Brain Decline In Fatal Childhood Disorder RARE Benzinga
Feb-03	EU Panel Rejects Acadia Pharmaceuticals Rett Syndrome Drug ACAD -5.24% Benzinga
Feb-03	DaVita Stock Rallies On Profit Beat, Confident 2026 View DVA +21.17% DVA +5.44% Benzinga
Feb-03	Medtronic Bets On AI Heart Care With $585 Million Deal For Partner CathWorks MDT Benzinga
Feb-03	Merck's Annual Outlook Falls Short But Keytruda, Animal Health Segments Grow MRK Benzinga
Feb-03	Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops PFE Benzinga
Feb-03	AstraZeneca Responds With Data After FDA Delays Lupus Drug Shot AZN Benzinga
Feb-02	Why Is Twist Bioscience Stock Soaring Monday? TWST +13.98% Benzinga
Feb-02	Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case AVTX NVS ABBV MLTX Benzinga
Feb-02	Wave Life Sciences Reclaims Rare Disease Drug From GSK, Targets Faster FDA Path WVE GSK Benzinga
Feb-02	Novo Nordisk's Next-Gen Combination Drug Beats Semaglutide in Weight Loss and Blood Sugar Control NVO -14.64% NVO Benzinga
Feb-02	Sanofi Found In Breach Of UK Pharmaceutical Marketing Code Over Beyfortus Claims PFE SNY Benzinga
Feb-02	Penny Stock Skye Bioscience Drug Combo With Wegovy Shows Over 22% Weight Loss After One Year NVO -14.64% SKYE -7.92% NVO LLY Benzinga
Feb-02	What's Going On With Aquestive Therapeutics Stock After FDA Update For Lead Allergic Treatment? AQST +38.98% SPRY Benzinga
Feb-02	FDA Moves To Bring Pharma Manufacturing Back To US With New Pilot LLY Benzinga
Feb-02	Why Is IDEXX Labs Stock Falling Today? IDXX Benzinga
Feb-02	Revvity Sees Steady Growth On Rising Demand From Pharma/Biotech Customers DHR RVTY TMO Benzinga
Feb-02	FDA Strikes Off European Biotech Pharming's Immune Deficiency Drug For Expanded Use In Pediatric Patients PHAR -17.07% Benzinga
Feb-02	Sanofi Plans Regulatory Submission For Investigational Drug For Rare Disease Despite Mixed Data From Pivotal Trials SNY Benzinga
Jan-30	Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends AMGN Benzinga
Jan-30	Analysts Maintain Bull Case On ResMed Despite Competition Concerns RMD Benzinga
Jan-30	New FDA-Approved Eye Drop Sparks Fresh Competition For LENZ Therapeutics' Drug LENZ -11.02% Benzinga
Jan-30	Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems ALC STAA Benzinga
Jan-30	Novo Nordisk Outspends Eli Lilly On Wegovy, Ozempic Ads After Supply Crunch Eases LLY ABBV NVO Benzinga
Jan-30	Regeneron Posts Lower Eylea Sales Amid Rising Competition, Plans $2 Billion New Factory SNY REGN Benzinga
Jan-30	Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic TEVA NVO Benzinga
Jan-30	Quince Therapeutics Stock Collapses After Key Trial Update In Rare Genetic Disease QNCX -37.06% Benzinga
Jan-30	AstraZeneca Expands Weight Loss Push With Eight-Program China Collaboration AZN Benzinga
Jan-30	Walmart Boosts Pharmacy Technician Pay As Health Push Accelerates WMT Benzinga
Jan-29	Eli Lilly Teams Up With Two Biotechs To Target Autoimmune Disease, Hearing Loss In Deals Worth $3 Billion LLY Benzinga
Jan-29	Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product GUTS -68.04% GUTS -21.35% Benzinga
Jan-29	Thermo Fisher Scientific Discloses How Much Clario Deal Could Add To Its EPS TMO Benzinga
Jan-29	Steel Partners Targets InMode, Citing Stock Underperformance INMD +5.95% Benzinga
Jan-29	Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination NEOG Benzinga
Jan-29	FDA Accepts Summit's Lung Cancer Drug Application, Review Underway SMMT -5.97% SMMT MRK ONC Benzinga
Jan-29	AstraZeneca Bets Big On China With Massive $15 Billion Investment AZN Benzinga
Jan-29	Takeda Flags Vyvanse Hit, Lifts 2025 Profit Guidance On Cost Control TAK Benzinga
Jan-29	Sanofi Warns Dupixent Is Too Big To Replace As Patent Clock Ticks SNY Benzinga
Jan-28	Halozyme Therapeutics Projects Sustained Growth Well Into 2040 HALO Benzinga
Jan-28	Hospital Operator HCA Healthcare Is Set For Solid Growth, Higher Value-Analyst HCA ARDT UHS Benzinga
Jan-28	FDA Clinical Hold Knocks REGENXBIO Stock RGNX -17.90% RGNX +5.36% Benzinga
Jan-28	Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook TEVA Benzinga
Jan-28	CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis CALC -75.59% CALC -18.40% Benzinga
Jan-28	US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026 ELV +5.86% Benzinga
Jan-28	Danaher Expects Gradual Improvement In End-Market Conditions DHR Benzinga
Jan-28	EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal FEED +119.05% Benzinga
Jan-28	Astrana Health Stock Slide Presents An Attractive Entry Point: Analyst ALHC +5.34% AGL ASTH Benzinga
Jan-28	Cardiff Oncology Stock Plunges After Sudden Leadership Change, Narrowed Trial Focus CRDF -19.00% Benzinga
Jan-28	Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle NVS PFE ABBV BMY LLY +4 More Benzinga
Jan-27	Aclaris Hair Loss Drug Shows Faster Results Than Pfizer's Drug PFE ACRS Benzinga
Jan-27	Intellia Moves Forward As FDA Removes Trial Hold For Rare Disorder NTLA -6.81% NTLA +6.31% Benzinga
Jan-27	Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication MESO Benzinga
Jan-27	Kazia Therapeutics Reports Positive Early Responses In Aggressive Breast Cancer Trial KZIA -9.84% KZIA -8.25% MRK Benzinga
Jan-27	Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments GNTA +18.46% GNTA -12.34% Benzinga
Jan-27	$100 Billion Market Cap Hospital Operator HCA Healthcare To Buy Back Stock Worth $10 Billion HCA +7.08% Benzinga
Jan-27	UnitedHealth's Revenue Outlook, Medicare Shock Spook Investors UNH -19.61% Benzinga
Jan-27	Medicare Shock Sends UnitedHealth, Humana And CVS Tumbling HUM -21.13% UNH -19.61% ELV -14.33% CVS -14.15% ALHC -11.97% +2 More Benzinga
Jan-27	Roche's Obesity Drug Helps Almost 87% People Lose At Least 10% Weight LLY NVO Benzinga
Jan-26	Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag COGT NVS PFE SNY Benzinga
Jan-26	Sarepta Says Elevidys Slows Duchenne Progression After Three Years SRPT +7.90% Benzinga
Jan-26	United Therapeutics Reports Early Success For External Liver Support In Acute Failure UTHR XMHQ FXH PINK Benzinga
Jan-26	Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday? RVMD -16.87% ERAS MRK Benzinga
Jan-26	Revolution Medicines Stock Sinks After Merck Deal Talks Collapse RVMD -16.87% MRK ABBV Benzinga
Jan-23	FTC Delays Drug Middlemen Case While Talks Move Forward UNH CI CVS Benzinga
Jan-23	Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain ABT Benzinga
Jan-23	Pfizer CEO Calls RFK's Vaccine Views Anti-Science, Warns US Falling Behind China In Health Research PFE Benzinga
Jan-23	CVRx Kicks Off One Of The Largest Heart Device Trials In History CVRX +11.43% Benzinga
Jan-23	FDA Issues Alert For Integra Wound Care Products Over Infection Fears IART Benzinga
Jan-23	ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software CLPT +10.34% CLPT -9.44% Benzinga
Jan-23	Novartis Positions US Strategy As Defense Against Rising Trade Levies NVS Benzinga
Jan-23	Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase XBI PCVX MEDI Benzinga
Jan-23	Weight Loss Drugs Market Is Crowded But Structure Therapeutics CEO Has A Strategy For It LLY GPCR NVO Benzinga
Jan-23	Sanofi Plans Regulatory Filings For Dupixent's Successor Despite Mixed Data From Pivotal Studies SNY Benzinga
Jan-22	Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million JANX +14.09% MRK BMY Benzinga
Jan-22	FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer ARKG +5.68% MRK LFSC GH PFE +1 More Benzinga
Jan-22	Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half HOTH Benzinga

Vandana Singh

Recent Articles by Vandana Singh

Upgrade your FINVIZ experience